An Order of Council has appointed Thursday 10 December 2026 as the date on which the remaining provisions of the Human Medicines (Authorisation by Pharmacists and Supervision by Pharmacy Technicians) Order 2025 will commence, in so far as they are not already in force. The first phase-authorising the hand‑out of ‘checked and bagged’ prescriptions-took effect on 7 January 2026. (cpe.org.uk)
Taken together, the 2025 Order amends the Medicines Act 1968, the Human Medicines Regulations 2012 and the Medicines for Human Use (Clinical Trials) Regulations 2004. The reforms create a statutory route for a pharmacist to authorise a registered pharmacy technician to undertake, or supervise others undertaking, specified dispensing‑related activities, with new regulation numbers 220A and 220B used in the Human Medicines Regulations. (gov.uk)
Under the model, authorisation can be specific or general, may be given orally or in writing, and can be varied or withdrawn. Pharmacists must have due regard to patient safety when giving an authorisation, with breaches addressed through professional regulation; the clinical check by a pharmacist remains essential. (gov.uk)
Scope varies by jurisdiction. The checked‑and‑bagged provision (regulation 220B) applies across the UK. Technician authorisation for preparation, assembly, dispensing, sale and supply (regulation 220A) will initially apply in Great Britain only, reflecting the current absence of statutory registration for pharmacy technicians in Northern Ireland. (plea.org.uk)
In hospital pharmacy, the Order enables registered pharmacy technicians to take primary responsibility for the preparation and assembly of medicinal products in aseptic facilities from 10 December 2026, once supporting standards are finalised. The Royal Pharmaceutical Society has said it will update QAAPS to reflect the changes. (rpharms.com)
Implementation is deliberately staged. The General Pharmaceutical Council has confirmed a consultation on draft standards and rules for superintendent and responsible pharmacists, with publication ahead of the wider commencement to underpin governance, accountability and documentation. (pharmaceutical-journal.com)
Parliamentary debates have recorded ministerial assurances that the reforms do not remove the legal requirement for a responsible pharmacist to be signed in when a registered pharmacy is open to the public, and that supervision continues-what changes is who may be authorised to carry out or oversee defined tasks. (hansard.parliament.uk)
Policy Wire analysis: NHS providers, ICS commissioners and community pharmacy contractors now have a defined window to align SOPs, competence frameworks and indemnity. Priorities include setting task lists for general versus specific authorisations, documenting risk‑based exclusions, and escalation points for pharmacist intervention, consistent with the statutory duty to give due regard to patient safety. (gov.uk)
For NHS community pharmacies, sector guidance confirms the 7 January 2026 checked‑and‑bagged change may be used without amending the Terms of Service under the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013; contractors should still update SOPs and records accordingly. (cpe.org.uk)
With 10 December 2026 now fixed, organisations should schedule final readiness reviews in autumn 2026 and track forthcoming GPhC standards and RPS guidance so that authorisations, record‑keeping and aseptic governance are compliant on day one. (pharmaceutical-journal.com)